probenecid has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engler, CB | 1 |
| Sander, B | 1 |
| Larsen, M | 1 |
| Koefoed, P | 1 |
| Parving, HH | 1 |
| Lund-Andersen, H | 1 |
| Magoula, I | 1 |
| Tsapas, G | 1 |
| Paletas, K | 1 |
| Mavromatidis, K | 1 |
1 trial available for probenecid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Topics: Adult; Biological Transport, Active; Blood; Blood-Retinal Barrier; Capillary Permeability; Cross-Ove | 1994 |
1 other study available for probenecid and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Insulin-dependent diabetes and renal hypouricemia.
Topics: Adolescent; Adult; Creatinine; Diabetes Mellitus, Type 1; Female; Humans; Kidney Tubules; Male; Prob | 1991 |